41 results
Page 2 of 3
8-K
EX-10.1
gj6fxqhqeo1a4skygw
19 Mar 19
Entry into a Material Definitive Agreement
4:56pm
10-KT
l7x9p6lrumksuus0gfdq
26 Mar 18
Annual report (with FYE transition)
12:00am
424B5
jxkgfdscj6s
7 Oct 15
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
p1u2p5 b0n5r2f
7 Oct 15
Contravir Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants to Purchase Common Stock
12:00am
8-K
EX-10.1
ez2mdd 6myst
15 Oct 14
ContraVir Pharmaceuticals Closes $9.0 Million Financing to Advance Lead Shingles Candidate
12:00am
10-K
htv y8l9v54x21
29 Sep 14
Annual report
12:00am
10-12G/A
EX-99.1
eu2jz2
6 Feb 14
Registration of securities (amended)
12:00am
8-K
EX-10.1
ae157yt3
5 Feb 14
Entry into a Material Definitive Agreement
12:00am
10-12G/A
EX-99.1
1afk7x 439hvt1z
24 Dec 13
Registration of securities (amended)
12:00am
10-12G/A
EX-10.4
fjzcc
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
7fns 6eoa2ymghh83u
21 Nov 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
y4trk
22 Oct 13
Registration of securities (amended)
12:00am
10-12G/A
EX-99.1
eru32j
20 Sep 13
Registration of securities (amended)
12:00am
10-12G/A
EX-10.4
jo49cp042tqjo
20 Sep 13
Registration of securities (amended)
12:00am
10-12G
EX-10.1
y9bfwuf5mfunli
8 Aug 13
Registration of securities
12:00am